Skip to main content

Advertisement

Log in

The 3D-QSAR and pharmacophore studies of pyrimidine derivatives as HCV replication (replicase) inhibitor

  • Original Research
  • Published:
Medicinal Chemistry Research Aims and scope Submit manuscript

Abstract

Three-dimensional quantitative structure activity relationship has been carried out on a series of 211 pyrimidine derivatives as HCV replication (replicase) inhibitors to identify the chemical structural impacting the biological activities. The QSAR models based on 157 compounds screened as the training set and the rest as the test set were established by comparative molecular field analysis and molecular similarity indices analysis (CoMSIA) methods. The optimal CoMSIA model exhibits both satisfying internal and external prediction performance with q 2 = 0.501, \( R^{ 2}_{\text{ncv}} \; = \; 0. 9 6 2 \), \( R^{ 2}_{\text{pred}} \; = \; 0. 8 8 3 \). In addition, the 3D contour map analysis and the pharmacophoric features identified from corresponding pharmacophore study point out the key structural features that affect the inhibition activity of the pyrimidine analogs that (1) bulky substituents at position 11 and 23 are unfavorable; (2) minor positive 16 charges and H-bond donor groups at this position are benefit while H-bond acceptor near this position are detrimental; (3) substituents near Ring B: minor H-bond donor, H-bond acceptor groups are favorable; (4) electro-negative charges at position 7 and 9 are favorable while H-bond donor at position 9 are unfavorable; (5) two H-bond donor sites (DS1, DS2), two H-bond donor atoms (DA1, DA2); two H-bond acceptor atoms (AA1, AA2), hydrophobic and aromatic, and aromatic centers account for the pharmacophore features of the model.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  • Arasappan A, Bennett F, Girijavallabhan V, Huang Y, Huelgas R, Alvarez C, Chen L, Gavalas S, Kim SH, Kosinski A, Pinto P, Rizvi R, Rossman R, Shankar B, Tong L, Velazquez F, Venkatraman S, Verma VA, Kozlowski J, Shih NY, Piwinski JJ, MacCorss M, Kwong CD, Clark JL, Fowler AT, Geng F, Kezar HS III, Roychowdhury A, Reynolds RC, Maddry JA, Ananthan S, Secrist JA III, Li C, Chase R, Curry S, Huang HC, Tong X, Njoroge FG (2012) 5-Benzothiazole substituted pyrimidine derivatives as HCV replication (replicase) inhibitors. Bioorg Med Chem Lett 22:3229–3234

    Article  CAS  PubMed  Google Scholar 

  • Bennett F, Kezar HS III, Girijavallabhan V, Huang Y, Huelgas R, Rossman R, Shih NY, Piwinski JJ, MacCoss M, Kwong CD, Clark JL, Fowler AT, Geng F, Roychowdhury A, Reynolds RC, Maddry JA, Ananthan S, Secrist JA III, Li C, Chase R, Curry S, Huang HC, Tong X, George Njoroge F, Arasappan A (2012) Pyridofuran substituted pyrimidine derivatives as HCV replication (replicase) inhibitors. Bioorg Med Chem Lett 22:5144–5149

    Article  CAS  PubMed  Google Scholar 

  • Böhm M, Stürzebecher J, Klebe G (1999) Three-dimensional quantitative structure-activity relationship analyses using comparative molecular field analysis and comparative molecular similarity indices analysis to elucidate selectivity differences of inhibitors binding to trypsin, thrombin, and factor Xa. J Med Chem 42:458–477

    Article  PubMed  Google Scholar 

  • Chen G, Ren H, Turpoff A, Arefolov A, Wilde R, Takasuqi J, Khan A, Almstead N, Gu Z, Komatsu T, Freund C, Breslin J, Colacino J, Hedrick J, Weetall M, Karp GM (2013) Discovery of N-(4’-(indol-2-yl)phenyl)sulfonamides as novel inhibitors of HCV replication. Bioorg Med Chem Lett 23:3942–3946

    Article  CAS  PubMed  Google Scholar 

  • Clark M, Cramer RD III, Opdenbosch NV (1989) Validation of the general purpose Tripos 5.2 force field. J Comput Chem 10:982–1012

    Article  CAS  Google Scholar 

  • Cramer RD, Patterson DE, Bunce JD (1988) Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J Am Chem Soc 110:5959–5967

    Article  CAS  PubMed  Google Scholar 

  • Deshpande S, Jaiswal S, Katti SB, Prabhakar YS (2011) CoMFA and CoMSIA analysis of tetrahydroquinolines as potential antimalarial agents. SAR QSAR Environ Res 22:473–488

    Article  CAS  PubMed  Google Scholar 

  • Gasteiger J, Marsili M (1980) Iterative partial equalization of orbital electronegativity—a rapid access to atomic charges. Tetrahedron 36:3219–3228

    Article  CAS  Google Scholar 

  • Girijavallabhan VM, Alvarez C, Bennett F, Chen L, Gavalas S, Huang Y, Kim SH, Kosinski A, Pinto P, Rizvi R, Rossman R, Shankar B, Tong L, Velazquez F, Venkatraman S, Verma VA, Kozlowski J, Shih NY, Piwinski JJ, MacCoss M, Kwong CD, Bansal N, Clark JL, Fowler AT, Kezar HS III, Valiyaveettil J, Reynolds RC, Maddry JA, Ananthan S, Secrist JA III, Li C, Chase R, Curry S, Huang HC, Tong X, Njoroge FG, Arasappan A (2012) Synthesis and SAR of pyridothiazole substituted pyrimidine derived HCV replication inhibitors. Bioorg Med Chem Lett 22:5652–5657

    Article  CAS  PubMed  Google Scholar 

  • Golbraikh A, Tropsha A (2002) Beware of q2! J Mol Graph Model 20:269–276

    Article  CAS  PubMed  Google Scholar 

  • Halfon P, Locarnini P (2011) Hepatitis C virus resistance to protease inhibitors. J Hepatol 55:192–206

    Article  CAS  PubMed  Google Scholar 

  • Hao M, Ren H, Luo F, Zhang S, Qiu J, Ji M, Si H, Li G (2012) A Computational Study on Thiourea Analogs as Potent MK-2 Inhibitors. Int J Mol Sci 13:7057–7079

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Huang C, Li Y, Ren H, Wang J, Shao L, Zhang S, Li G, Yang L (2012) Insight into the structural determinants of imidazole scaffold-based derivatives as p38 MAP kinase inhibitors by computational explorations. Curr Med Chem 19:4024–4037

    Article  CAS  PubMed  Google Scholar 

  • Karoney MJ, Siika AM (2013) Hepatitis C virus (HCV) infection in Africa: a review. Pan Afr Med J 14(44):2199

    Google Scholar 

  • Kim CW, Chang KM (2013) Hepatitis C virus: virology and life cycle. Clin Mol Hepatol 19:17–25

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Klebe G, Abraham U, Mietzner T (1994) Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. J Med Chem 37:4130–4146

    Article  CAS  PubMed  Google Scholar 

  • Kwong CD, Clark JL, Fowler AT, Geng F, Kezar HS III, Roychowdhury A, Reynolds RC, Maddry JA, Ananthan S, Secrist JA III, Shih NY, Piwinski JJ, Li C, Feld B, Huang HC, Tong X, George Njoroge F, Arasappan A (2012) Novel substituted pyrimidines as HCV replication (replicase) inhibitors. Bioorg Med Chem Lett 22:1160–1164

    Article  CAS  PubMed  Google Scholar 

  • Liu J, Zhang H, Xiao Z, Wang F, Wang X, Wang Y (2011) Combined 3D-QSAR, molecular docking and molecular dynamics study on derivatives of peptide epoxyketone and tyropeptin-boronic acid as inhibitors against the β5 subunit of human 20S proteasome. Int J Mol Sci 12:1807–1835

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Lv Y, Yin C, Liu H, Yi Z, Wang Y (2008) 3D-QSAR study on atmospheric half-lives of POPs using CoMFA and CoMSIA. J Environ Sci (China) 20:1433–1438

    Article  CAS  Google Scholar 

  • Mao Y, Li Y, Hao M, Zhang S, Ai C (2012) Docking, molecular dynamics and quantitative structure-activity relationship studies for HEPTs and DABOs as HIV-1 reverse transcriptase inhibitors. J Mol Model 18:2185–2198

    Article  CAS  PubMed  Google Scholar 

  • Nguyen LH, Nguyen MH (2013) Systematic review: Asian patients with chronic hepatitis C infection. Aliment Pharmacol Ther 37:921–936

    Article  CAS  PubMed  Google Scholar 

  • Njoroge FG, Chen KX, Shih NY, Piwinski JJ (2008) Challenges in modern drug discovery: a case study of boceprevir, an HCV protease inhibitor for the treatment of hepatitis C virus infection. Acc Chem Res 41:50–59

    Article  CAS  PubMed  Google Scholar 

  • O’Leary JG, Davis GL (2010) Hepatitis C virus replication and potential targets for direct-acting agents. Therap Adv Gastroenterol 3:43–53

    Article  PubMed Central  PubMed  Google Scholar 

  • Rosen HR (2011) Clinical practice. Chronic hepatitis C infection. N Engl J Med 364:2429–2438

    Article  CAS  PubMed  Google Scholar 

  • Tong J, Wang YW, Lu YA (2012) New developments in small molecular compounds for anti-hepatitis C virus (HCV) therapy. J Zhejiang Univ Sci B 13:56–82

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Verma VA, Rossman R, Bennett F, Chen L, Gavalas S, Girijavallabhan V, Huang Y, Kim SH, Kosinski A, Pinto P, Rizvi R, Shankar B, Tong L, Velazquez F, Venkatraman S, Kozlowski J, MacCorss M, Kwong CD, Bansal N, Kezar HS III, Reynolds RC, Maddry JA, Ananthan S, Secrist JA III, Li C, Chase R, Curry S, Huang HC, Tong Z, Njoroge FG, Arasappan A (2012) Synthesis and SAR of geminal substitutions at the C5’ carbosugar position of pyrimidine-derived HCV inhibitors. Bioorg Med Chem Lett 22:6967–6973

    Article  CAS  PubMed  Google Scholar 

  • Wang Y, Han KL, Yang SL, Yang L (2004) Structural determinants of steroids for cytochrome P450 3A4-mediated metabolism. J Mol Struct (Theochem) 710:215–221

    Article  CAS  Google Scholar 

  • Wang Z, Kai Z, Beier RC, Shen J, Yang X (2012) Investigation of antigen-antibody interactions of sulfonamides with a monoclonal antibody in a fluorescence polarization immunoassay using 3D-QSAR models. Int J Mol Sci 13:6334–6351

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Wei SP, Ji ZQ, Zhang HX, Zhang JW, Wang YH, Wu WJ (2011) Isolation, biological evaluation and 3D-QSAR studies of insecticidal/narcotic sesquiterpene polyol esters. J Mol Model 17:681–693

    Article  CAS  PubMed  Google Scholar 

  • Wilby KJ, Partovi N, Ford JA, Greanya E, Yoshida EM (2012) Review of boceprevir and telaprevir for the treatment of chronic hepatitis C. Can J Gastroenterol 26:205–210

    PubMed Central  PubMed  Google Scholar 

  • Wold S, Geladi P, Esbensen K, Öhman J (1987) Multiway principal components and pls-analysis. J Chemometr 1:41–56

    Article  CAS  Google Scholar 

  • Zhang MQ, Zhang XL, Li Y, Fan WJ, Wang YH, Hao M, Zhang SW, Ai CZ (2011) Investigation on quantitative structure activity relationships and pharmacophore modeling of a series of mGluR2 antagonists. Int J Mol Sci 12:5999–6023

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Zhang HX, Li Y, Wang X, Wang YH (2012) Probing the structural requirements of A-type Aurora kinase inhibitors using 3D-QSAR and molecular docking analysis. J Mol Model 18:1107–1122

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

Thanks for the financial support given by the National Natural Science Foundation of China (Grant No. 11201049). The authors thank Liping Tian and Qiusheng Zheng (from Shihezi University) for their technological assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yan Li.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 1606 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, Y., Wang, D., Yang, Y. et al. The 3D-QSAR and pharmacophore studies of pyrimidine derivatives as HCV replication (replicase) inhibitor. Med Chem Res 24, 2033–2042 (2015). https://doi.org/10.1007/s00044-014-1256-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00044-014-1256-x

Keywords

Navigation